31.08.2013 Views

towards improved death receptor targeted therapy for ... - TI Pharma

towards improved death receptor targeted therapy for ... - TI Pharma

towards improved death receptor targeted therapy for ... - TI Pharma

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MATERIALS & METHODS<br />

TRAIL‐induced migration and invasion<br />

Cell lines and chemicals<br />

NSCLC cells, H460, H322, SW1573, and A549, derived from ATCC in 2003, were cultured<br />

as monolayers in RPMI 1640 medium, supplemented with 10% (v/v) FBS, 100 units/ml<br />

penicillin, and 100 µg/ml streptomycin. Cells were maintained in a humidified 5% CO2<br />

atmosphere at 37°C. The cell lines were tested <strong>for</strong> their authenticity by short tandem<br />

repeats (STR) profiling DNA fingerprinting (Baseclear, Leiden, The Netherlands). PP2,<br />

PD098059 (Sigma‐Aldrich, St. Louis, MO, USA), dasatinib and saracatinib (both from LC<br />

Laboratories, Woburn, MA, USA) were dissolved in DMSO to 20 mM stock solutions.<br />

LY294002 (Sigma‐Aldrich) was dissolved in DMSO to 10 mM stock solution.<br />

MTT assay<br />

A total of 10,000 cells were seeded in 96‐well plates (Greiner Bio‐One, Frickenhausen,<br />

Germany). The next day 100 µl medium with or without TRAIL was added with increasing<br />

concentrations to the cells. After 24 h incubation, the medium was discarded and 50 µl of<br />

a MTT solution (0.5 mg/ml (Sigma‐Aldrich) in HBSS) was added and incubated at 37°C <strong>for</strong><br />

1.5 h. The <strong>for</strong>mazan crystals were dissolved using 150 µl dimethyl sulfoxide (DMSO) and<br />

absorbance was measured at 540 nm (Tecan, Männedorf, Switzerland). Results are<br />

presented as percentage of viable cells taking the control (untreated cells) as 100%<br />

survival. The concentration resulting in 50% of cell growth inhibition (IC50) was derived<br />

from the growth inhibition curve.<br />

Receptor cell surface expression<br />

Analysis of TRAIL‐<strong>receptor</strong> membrane expression was per<strong>for</strong>med using a flow cytometer<br />

(Epics Elite, Coulter‐Electronics, Hialeah, FL, USA). Adherent cells were harvested by<br />

treatment with trypsin and washed twice in PBS containing 1% BSA. Appropriate<br />

concentrations of antibodies dissolved in PBS/1% BSA were added to the cells. The<br />

following antibodies were used to determine TRAIL <strong>receptor</strong> membrane expression:<br />

TRAIL‐R1 (HS101), TRAIL‐R2 (HS201), TRAIL‐R3 (HS301), TRAIL‐R4 (HS402), all from Alexis.<br />

Mouse IgG (DAKO) was used as isotype control. Subsequently, cells were incubated <strong>for</strong><br />

30 min on ice, washed twice with cold PBS/1% BSA, and incubated with FITC‐conjugated<br />

rabbit‐antimouse (DAKO, Glostrup, Denmark) <strong>for</strong> 30 min on ice. After washing, the cells<br />

were analyzed by flow cytometry. Surface expression is shown as a ratio of the signal of<br />

the specific TRAIL‐<strong>receptor</strong> antibody and the negative isotype control antibody.<br />

Migration assays<br />

Cell migration was determined using the wound healing assay as described previously<br />

[13]. In brief, NSCLC cells were seeded in 96‐wells plates and grown till confluence. A 96<br />

well floating‐pin transfer device with a pin diameter of 1.58 mm coming to a flat point at<br />

‐ 63 ‐

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!